Correlation Between Akero Therapeutics and Axsome Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Axsome Therapeutics, you can compare the effects of market volatilities on Akero Therapeutics and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Axsome Therapeutics.
Diversification Opportunities for Akero Therapeutics and Axsome Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Akero and Axsome is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Axsome Therapeutics go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Axsome Therapeutics
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 1.04 times less return on investment than Axsome Therapeutics. In addition to that, Akero Therapeutics is 1.47 times more volatile than Axsome Therapeutics. It trades about 0.1 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.15 per unit of volatility. If you would invest 9,011 in Axsome Therapeutics on August 28, 2024 and sell it today you would earn a total of 739.00 from holding Axsome Therapeutics or generate 8.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Axsome Therapeutics
Performance |
| Timeline |
| Akero Therapeutics |
| Axsome Therapeutics |
Akero Therapeutics and Axsome Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Axsome Therapeutics
The main advantage of trading using opposite Akero Therapeutics and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.| Akero Therapeutics vs. Eliem Therapeutics | Akero Therapeutics vs. HCW Biologics | Akero Therapeutics vs. Scpharmaceuticals | Akero Therapeutics vs. Milestone Pharmaceuticals |
| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |